FFCP PHASE1:Hg19::chr12:57146095..57146149,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@PRIM1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_PRIM1_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000338193, ENST00000537418, ENST00000548173, ENST00000550224, ENST00000550770, ENST00000552853, NM_000946, uc001smd.2, uc001sme.1, uc001smf.2, uc009zoz.1_5end |
EntrezGene: | PRIM1 |
HGNC: | 9369 |
UniProt: | P49642F5H513F8VNY2 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@PRIM1 |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 4.08e-59 | 235 |
disease of cellular proliferation | 3.35e-57 | 239 |
cell type cancer | 4.43e-34 | 143 |
carcinoma | 4.11e-29 | 106 |
organ system cancer | 1.02e-26 | 137 |
hematologic cancer | 2.37e-22 | 51 |
immune system cancer | 2.37e-22 | 51 |
leukemia | 1.16e-18 | 39 |
myeloid leukemia | 5.81e-15 | 31 |
germ cell and embryonal cancer | 3.68e-07 | 22 |
Showing 1 to 10 of 12 entries